Background: The Single Ventricle Reconstruction Trial demonstrated increased risk of death or heart transplant 1 year after Norwood among subjects randomly assigned to modified Blalock-Taussig shunts compared with right ventricle to pulmonary artery (RV-PA) shunts. We used the Single Ventricle Reconstruction Trial public use database to evaluate incidence and risk factors for postoperative renal failure and relationships between renal failure, shunt type, and outcomes after Norwood.
Methods: Postoperative renal failure was defined a priori as a threefold rise in creatinine from baseline, or dialysis use, within 7 days of Norwood. We used multivariate logistic regression to evaluate risk factors for postoperative renal failure and Cox hazard regression to determine the association between postoperative renal failure and 1 year after Norwood mortality.
Results: Overall, postoperative renal failure occurred in 8.4% (46 of 544) patients with risk factors including receipt of a modified Blalock-Taussig shunt (adjusted odds ratio [aOR] 3.3, P = .02), low center volume (aOR 2.7, P = .005), two or more preoperative complications (aOR 4.0, P < .001), low birth weight (aOR 3.2, P = .002), postoperative heart block (aOR 8.5, P = .001), and delayed sternal closure (aOR 5.3, P = .026). Renal failure was an independent risk factor for 1-year mortality (aHR 1.9, P = .019). Assessing interaction by shunt type, mortality risk associated with renal failure was greatest in the RV-PA shunt group (aHR 3.3 vs RV-PA shunt without renal failure, P = .001), but was also increased in the modified Blalock-Taussig shunt group (aHR 1.9, P = .03).
Conclusions: Postoperative renal failure is common after Norwood and is independently associated with mortality. Although renal failure is more common after modified Blalock-Taussig shunt, the highest mortality risk with renal failure occurs after RV-PA shunt.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920938 | PMC |
http://dx.doi.org/10.1016/j.athoracsur.2021.08.019 | DOI Listing |
JAMA Intern Med
December 2024
The Rogosin Institute, New York, New York.
Importance: Chronic pain is common among individuals with dialysis-dependent kidney failure.
Objective: To evaluate the effectiveness of pain coping skills training (PCST), a cognitive behavioral intervention, on pain interference.
Design, Setting, And Participants: This multicenter randomized clinical trial of PCST vs usual care was conducted across 16 academic centers and 103 outpatient dialysis facilities in the US.
Alzheimers Dement
December 2024
Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China.
Background: Chronic kidney disease (CKD) has relatively high prevalence and independently increases dementia risk. Currently, there is a lack of high-performance dementia prediction tools designed for the CKD population in clinical practice. Through proteomics discovery, this study aimed to discover more efficient dementia risk models in CKD patients.
View Article and Find Full Text PDFBackground: This study aims to describe usage patterns and risk factors associated with anticoagulant therapy in patients with mild cognitive impairment (MCI) or Alzheimer's disease (AD).
Methods: The United States Medicare claims database (2008- 18) was used to identify patients aged ≥65 years with MCI or AD and to evaluate their anticoagulant use from 2016- 17. A random sample of new anticoagulant users (n = 21,069) was selected.
Background: The increasing incidence of cognitive impairment in older adults poses significant, complex challenges for patients and their families. While specialists have traditionally addressed this care, there is an urgent need to shift diagnosis and management of mild cognitive impairment (MCI) and dementia to primary care. The annual wellness visit for Medicare recipients provides an excellent opportunity for primary care providers (PCPs) to assess patients who may need a cognitive evaluation.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
San Francisco Veterans Affairs Health Care System, San Francisco, CA, USA.
Background: Cardiovascular-Kidney-Metabolic Syndrome (CKM), a systemic interplay among metabolic risk factors, chronic kidney disease (CKD), and cardiovascular disease (CVD), has profound impacts on cardiovascular events and mortality, yet its association with dementia risk remains poorly understood. With data from the Health, Aging, and Body Composition study, we investigated the association between CKM and dementia risk among older adults.
Method: We studied 2,722 participants (mean age 74 ± 2.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!